References
- Liliemark J, Juliusson G. 2-Chloro-2′-deoxyadenosine—clinial, biochemical, and pharmacokinetic considerations. Arch Immunol Ther Exp 1994; 42: 7–10
- Saven A, Figueroa M L, Piro L D, Rosenblatt J D. 2-Chlorodeoxyadenosine to treat refractory histiocytosis X. N Engl J Med 1993; 329: 734–735
- Histiocyte Society. LCH II Treatment Protocol. May, 1996
- Histiocyte Society. LCH III Treatment Protocol. April, 2001
- Carrera C J, Terai C, Lotz M, Curd J G, Piro L D, Beutler E, Carson D A. Potent toxicity of 2-chlorodeoxyadenosine toward human monocytes in vitro and in vivo: a novel approach to immunosuppressive therapy. J Clin Invest 1990; 86: 1480–1488
- Goh N SL, MacDonald C HF, MacGregor D P, Presto J J, Brodie G N. Successful treatment of Langerhans cell histiocytosis with 2-chlorodeoxyadenosine. Respirology 2003; 8: 91–94
- Weitzman S, Wayne A S, Arceci R, Lipton J M, Whitlock J A. Nucleoside analogues in the therapy of Langerhans cell histiocytosis: a survey of members of the histiocyte society and review of the literature. Med Pediatr Oncol 1999; 33: 476–481
- Rodriguez-Galindo C, Kelly P, Jeng M, Presbury G G, Rieman M, Wang W. Treatment of children with Langerhans cell histiocytosis with 2-chlorodeoxyadenosine. Am J Hematol 2002; 69: 179–184
- Grau J, Ribera J M, Tormo M, Indiano J M, Vercher J, Sandoval V, et al. Results of treatment with 2-chlorodeoxyadenosine in refractory or relapsed Langerhans cell histiocytosis. Study of 9 patients. Med Clin (Barc) 2001; 116: 339–342
- Stine K C, Saylors R L, Saccente S, McClain K L, Becton D L. Efficacy of continuous infusion 2-CDA (cladribine) in pediatric patients with Langerhans cell histiocytosis. Pediatr Blood Cancer 2004; 43: 81–84
- McCowage G B, Frush D P, Kurtzberg J. Successful treatment of two children with Langerhans' cell histiocytosis with 2′-deoxycoformycin. J Pediatr Hematol Oncol 1996; 18: 154–158
- Pardanani A, Phyliky R L, Li C Y, Tefferi A. 2-Chlorodeoxyadenosine therapy for disseminated Langerhans cell histiocytosis. Mayo Clin Proc 2003; 78: 301–306
- Choi S W, Bangaru B S, Wu C D, Finlay J L. Gastrointestinal involvement in disseminated Langerhans cell histiocytosis (LCH) with durable complete response to 2-chlorodeoxyadenosine and high-dose cytarabine. J Pediatr Hematol Oncol 2003; 25: 503–506
- Bernard F, Thomas C, Bernard Y, Munzer M, Landman Parker J, Ouache M, et al. Multi-centre pilot study of 2-chlorodeoxyadenosine and cytosine arabinoside chemotherapy in refractory Langerhans cell histiocytosis with haematological dysfunction. Eur J Cancer 2005; 41: 2682–2689
- Weitzman S, Pritchard J. Getting there? Salvage therapy for refractory Langerhans cell histiocytosis in children. Eur J Cancer 2005; 41: 2592–2594